Keyphrases
Arteriovenous Passage Time
25%
Bonferroni Method
25%
Capillary
50%
Central Retinal Artery
25%
Ciliary Artery
25%
Color Doppler Imaging
25%
Dorzolamide
100%
Flow Parameters
25%
Flow Velocity
25%
Fluorescein Angiogram
25%
Glaucoma
50%
Glaucoma Patients
100%
Hemodynamic Effects
25%
Intraocular Pressure Reduction
25%
Macular
25%
Non-simultaneous
25%
Ocular Blood Flow
100%
Ophthalmic Artery
25%
Optic Disc
25%
Placebo
25%
Placebo Groups
25%
Previously Untreated
100%
Primary Open-angle Glaucoma
25%
Retina
25%
Retinal Circulation
25%
Retrobulbar
75%
Scanning Laser Ophthalmoscope
25%
Simultaneous Testing
25%
Topical Dorzolamide
50%
Treatment Trials
25%
Vascular Effects
25%
Medicine and Dentistry
Angiography
16%
Arm
16%
Capillary
33%
Central Retinal Artery
16%
Ciliary Artery
16%
Color Doppler Flowmetry
16%
Dorzolamide
100%
Fluorescein
16%
Glaucoma
100%
Hemodynamic
16%
Intraocular Pressure
16%
Ocular Blood Flow
100%
Open Angle Glaucoma
16%
Ophthalmic Artery
16%
Optic Disc
16%
Placebo
33%
Retina Blood Flow
16%
Scanning Laser Ophthalmoscope
16%
Neuroscience
Angiography
16%
Central Retinal Artery
16%
Dorzolamide
100%
Fluorescein
16%
Glaucoma
100%
Intraocular Pressure
16%
Ocular Blood Flow
100%
Open-Angle Glaucoma
16%
Ophthalmic Artery
16%
Placebo
33%
Short Posterior Ciliary Arteries
16%
Pharmacology, Toxicology and Pharmaceutical Science
Agents Acting on the Eye
16%
Dorzolamide
100%
Fluorescein
16%
Glaucoma
100%
Open Angle Glaucoma
16%
Placebo
33%